EurekAlert! Cancer Research - News Releases

News Releases

Updates every hour. Last Updated: 23-Oct-2026 07:16 ET (23-Oct-2026 11:16 GMT/UTC)

Oral therapy protects healthy tissue from radiation in mice

Virginia Tech
Peer-Reviewed Publication

Researchers at the Fralin Biomedical Research Institute at VTC developed an experimental oral therapy that protected mice from harmful radiation while preserving radiation’s ability to fight cancer. The treatment reduced damage to vulnerable tissues and improved survival after whole-body radiation exposure. The findings could lead to better protection for cancer patients and new medical countermeasures for radiological emergencies.

Journal: Cancer Letters
Funder: Red Gates Foundation

Too few eligible Americans discuss lung screening: UC study

University of Cincinnati
Peer-Reviewed Publication

University of Cincinnati Cancer Center researchers have published a study in the American Journal of Surgery that found only 15% of eligible American adults have discussed lung cancer screening with their doctors.This research emphasizes the need to spread awareness and better educate the public about screening through low-dose computed tomography.

Journal: The American Journal of Surgery

Researchers uncovered how loss of NF1 drives ER+ breast cancer to metastasize to the bone

Baylor College of Medicine
Peer-Reviewed Publication

A Baylor College of Medicine-led team has uncovered how loss of tumor suppressor neurofibromin (NF1) in estrogen receptor-positive (ER+) breast cancer cells drives the cells’ preference to metastasize to the bone.

Journal: Cancer Letters

New drug combination may help treat advanced prostate cancer

Michigan Medicine - University of Michigan
Peer-Reviewed Publication

University of Michigan researchers identified two pathways that can simultaneously be targeted to treat transdifferentiated prostate tumors.

Journal: JCI Insight
Funder: Michigan Prostate SPORE, University of Michigan Rogel Cancer Center, Department of Defense

Scientists identify molecule driving one of the deadliest forms of breast cancer

Adelaide University
Peer-Reviewed Publication

Australian researchers have identified a molecular switch that drives the spread of the most aggressive sub-type of breast cancer (triple-negative breast cancer), potentially paving the way for more effective treatments.

Journal: EMBO Molecular Medicine
Funder: National Breast Cancer Foundation, National Health and Medical Research Council

Blood-camouflaged liquid metal nanoparticles defeat the most aggressive breast cancer

Tohoku University
Peer-Reviewed Publication

Triple-negative breast cancer (TNBC) accounts for roughly 15–20% of all breast cancer cases and is difficult to treat. Patients are often left with chemotherapy as their only treatment option. This is because TNBC tumors contain a large number of T cells that suppress the immune system. Yet researchers from Tohoku University have come up with a three-pronged approach to overcome this problem.

Journal: Advanced Science

KAIST develops core technology to reverse biological changes once thought irreversible, opening new possibilities for aging and cancer research

The Korea Advanced Institute of Science and Technology (KAIST)
Peer-Reviewed Publication

- KAIST research team led by Professor Kwang-Hyun Cho identifies the ‘molecular lock’ that keeps cells trapped in an altered state

- Team develops technology to release the lock and restore cells to their original condition, opening new possibilities for cancer and aging research

Journal: Proceedings of the National Academy of Sciences

ACCESS study points to broader stem cell donor options for blood cancer patients

University of Miami Miller School of Medicine
Peer-Reviewed Publication

A long-standing rule in stem cell transplantation is being challenged. New ACCESS trial findings in Blood Advances show encouraging outcomes with younger, more genetically mismatched unrelated donors. Lead author Antonio Jimenez Jimenez, M.D., can discuss how the findings are reshaping donor selection and patient care.

Journal: Blood Advances

Younger adults with lung cancer more likely to have targetable genetic changes, study finds

University of Miami Miller School of Medicine
Meeting Announcement

A large international study of more than 14,000 patients with non-small cell lung cancer found that younger adults were significantly more likely than older patients to have genetic alterations that can be targeted with existing therapies. The findings suggest age may be an overlooked factor in lung cancer biology and treatment decisions.

Mapping gene expression and epigenetic changes that cause "undead" cancer cells to trigger cancer-promoting inflammation

Rockefeller University
Peer-Reviewed Publication

Senescence is a state in which stressed cells stop dividing but remain alive. New findings reveal that the underlying process unfolds in distinct stages that depend on the type of drug used, and show how a new class of drugs triggers inflammation. The results point the way to a strategy for tuning therapies to avoid inflammation-promoting side effects, particularly for patients with liposarcoma and ER-positive breast cancer.

Journal: Life Science Alliance

71
72
73
74
75